drug design 蒋学华、王凌 四川大学华西药学院...
Post on 16-Mar-2016
463 Views
Preview:
DESCRIPTION
TRANSCRIPT
-
drug design
-
drug design
ADME
-
0.91.3
-
lead compoundprototype
drug delivery system,DDS
;
-
(Accidentally Discover)
(From Active Component Of Natural Resources)
From Immanent Active Substance
From Side-Effect Of Medicine
From Active MetabolitesBy Combinatorial Chemistry
(Rational Drug Design, RDD) Computer-aided Drug Design, CADD
-
(optimization)
-
target-based drug design:
structure-based drug design:
-
Properties Based Drug Design, PBDDADME
-
Structure-pharmacokinetics Relationship, SPRStructure-activity Relationship, SAR
Quantitative Structure-pharmacokinetics Relationship, QSPRQuantitative structure-pharmacokinetics relationship QSPR
-
Absorption, ADistribution, DMetabolism, MpH Excretion, E
Transport(Elimination) Disposition)
-
/ (Passive transport) (Carrier-mediated transport) (Membrane mobile transport )
-
/
-
//
-
TransportersMembrane Transport Proteins -ACEPepT1
-
Paracellular TransportTight Junction, TJ30100nm
6080 nm2938 nm23 nm
-
logD7.4pH
-
rifampicinrifamycinVdClrifabutin
-
710 m7 mMPS6090%2%10%3%10%50 nm
-
Drug Likeness
-
ADME
-
LipinskiThe LipinskiRule of Five
501000logDpKa
-
logPlogDlogPPlog PHanschLopPADME
-
pHlogDlogDlogPpKapH
-
IAMCaco-2MDCK
-
PAMPAUV
5%PAMPACaco-2PAMPA
-
11793242124641500110020
-
>5005100
>551
>1052
logP>5(ClogP)>4.15(MlogP)(51)
90%
(Rule of Five)
-
BayesianACDAvailable Chemicals Directory Database3500CMC3500CMC90%ACD10%MDDRMDL Drug Data Report80%
-
metoprololCYP2D6betaxolol
-
amlodipinefelodipinenifedipinenitrendipine
-
Solid DispersionInclusion CompoundsMicroemulsionsEmulsionMicroparticles Microcapsules MicrospheresNanoparticles Nanospheres NanocapsulesLiposomes
-
BCS
-
37pH1-7.5/D:S)250ml90%FDA/Caco-290%
-
Coating MaterialMembrane WallMicrocapsules/MicrospheresMicroparticles1250 mMicroencapsulation
-
(Nanospheres)(Nanocapsules)(Nanoparticles)101000nm
-
ADME/T
ADME/T
ADME/T
ADME/T
-
1964198431950.4%ADME/T
*2002FDA10030
*R&D
*QC
*
**
top related